| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 403.15M | 494.26M | 463.12M | 363.92M | 128.87M |
| Gross Profit | 211.13M | 225.37M | 238.23M | 209.54M | 44.99M |
| EBITDA | 106.36M | 86.62M | 70.34M | 94.02M | 16.93M |
| Net Income | 10.59M | -12.62M | -20.50M | 25.38M | -12.65M |
Balance Sheet | |||||
| Total Assets | 471.28M | 479.44M | 516.81M | 476.81M | 372.13M |
| Cash, Cash Equivalents and Short-Term Investments | 192.17M | 182.43M | 179.32M | 128.16M | 161.77M |
| Total Debt | 88.76M | 99.75M | 130.28M | 127.58M | 42.49M |
| Total Liabilities | 323.72M | 342.68M | 366.10M | 305.54M | 226.56M |
| Stockholders Equity | 147.56M | 136.76M | 150.71M | 171.27M | 145.57M |
Cash Flow | |||||
| Free Cash Flow | 112.07M | 58.24M | 72.67M | -67.61M | 19.07M |
| Operating Cash Flow | 114.02M | 84.45M | 99.45M | 44.03M | 24.54M |
| Investing Cash Flow | -30.95M | -59.00M | -37.84M | -97.51M | 52.20M |
| Financing Cash Flow | -50.03M | -55.59M | -21.92M | -28.73M | -14.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$673.75M | 7.71 | 23.07% | 5.98% | -0.19% | 19.04% | |
66 Neutral | HK$1.42B | 4.60 | 36.52% | 9.92% | -23.31% | -44.61% | |
63 Neutral | HK$5.09B | 21.31 | 70.23% | ― | 56.28% | -9.91% | |
62 Neutral | HK$376.00M | 34.56 | 11.48% | ― | -20.59% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | HK$81.40M | 2.59 | 10.10% | ― | -3.40% | 515.63% |